IRIS
GARRIBBA, Eugenio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.098
AS - Asia 6.444
EU - Europa 3.773
SA - Sud America 3.647
Continente sconosciuto - Info sul continente non disponibili 385
AF - Africa 264
OC - Oceania 17
Totale 28.628
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.709
BR - Brasile 3.233
SG - Singapore 2.689
CN - Cina 1.792
UA - Ucraina 1.159
IT - Italia 709
HK - Hong Kong 611
DE - Germania 489
VN - Vietnam 419
SE - Svezia 329
FI - Finlandia 249
FR - Francia 243
GB - Regno Unito 210
CA - Canada 147
AR - Argentina 137
TR - Turchia 131
BD - Bangladesh 128
MX - Messico 118
IN - India 102
IQ - Iraq 91
RU - Federazione Russa 82
ZA - Sudafrica 67
EC - Ecuador 66
VE - Venezuela 60
JP - Giappone 58
UZ - Uzbekistan 57
MA - Marocco 56
CO - Colombia 54
PL - Polonia 47
ID - Indonesia 44
PK - Pakistan 43
ES - Italia 42
NL - Olanda 42
KR - Corea 34
KE - Kenya 29
PY - Paraguay 28
AZ - Azerbaigian 25
JM - Giamaica 24
JO - Giordania 24
HN - Honduras 23
OM - Oman 22
UY - Uruguay 22
NP - Nepal 21
AE - Emirati Arabi Uniti 20
BE - Belgio 20
CL - Cile 19
CZ - Repubblica Ceca 19
PE - Perù 19
CR - Costa Rica 18
SA - Arabia Saudita 18
EG - Egitto 17
KZ - Kazakistan 17
TN - Tunisia 17
DZ - Algeria 16
PH - Filippine 16
AT - Austria 15
AU - Australia 15
RO - Romania 13
RS - Serbia 13
LT - Lituania 12
IL - Israele 11
SN - Senegal 11
BY - Bielorussia 10
AO - Angola 9
MY - Malesia 9
NI - Nicaragua 9
CH - Svizzera 8
DO - Repubblica Dominicana 8
EU - Europa 8
GT - Guatemala 8
IE - Irlanda 8
LB - Libano 8
PS - Palestinian Territory 8
SV - El Salvador 8
AL - Albania 7
GA - Gabon 7
GR - Grecia 7
PT - Portogallo 7
BO - Bolivia 6
CG - Congo 6
EE - Estonia 6
ET - Etiopia 6
GE - Georgia 6
KG - Kirghizistan 6
NG - Nigeria 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
PR - Porto Rico 5
QA - Qatar 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
IR - Iran 4
PA - Panama 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
TW - Taiwan 4
CI - Costa d'Avorio 3
GP - Guadalupe 3
HU - Ungheria 3
MD - Moldavia 3
Totale 28.203
Salva come PNG Salva come JPEG
Città #
Dallas 4.010
Singapore 1.460
San Jose 1.254
Chandler 1.222
Ashburn 802
Jacksonville 672
Council Bluffs 625
Hong Kong 603
Princeton 415
Santa Clara 388
Beijing 342
Columbus 310
Nanjing 256
São Paulo 241
Dearborn 236
Lauterbourg 203
Wilmington 185
Milan 169
Ho Chi Minh City 144
Shanghai 140
Boardman 121
Los Angeles 121
Hanoi 108
Nanchang 97
Rio de Janeiro 91
Ann Arbor 86
New York 86
Belo Horizonte 84
Tianjin 80
Helsinki 71
Woodbridge 67
Shenyang 64
Brasília 60
Tokyo 54
Hebei 53
Tashkent 53
The Dalles 51
Sassari 50
San Francisco 49
Changsha 47
Curitiba 47
Frankfurt am Main 47
Jiaxing 46
Campinas 44
Washington 43
Atlanta 40
Baghdad 39
Izmir 39
Phoenix 38
Toronto 38
Warsaw 38
Buffalo 37
Mountain View 37
Jinan 35
Norwalk 35
Rome 35
Falls Church 34
Brooklyn 33
Miano 33
Montreal 33
Hangzhou 32
Porto Alegre 32
Salvador 32
Zhengzhou 32
Orem 31
Johannesburg 30
Kunming 30
Seoul 30
Chicago 29
Denver 29
Houston 29
Ningbo 29
Amsterdam 28
Andover 28
Mexico City 28
Dhaka 27
Munich 27
Campo Grande 26
Guarulhos 26
Santo André 26
Baku 25
Nairobi 25
São José dos Campos 25
Falkenstein 24
London 24
Amman 23
Sorocaba 23
Chennai 22
Goiânia 22
Naples 22
Quito 22
Ribeirão Preto 21
Boston 20
Haiphong 20
Manaus 20
Montevideo 20
Recife 20
Seattle 20
Stockholm 20
Brussels 19
Totale 16.959
Salva come PNG Salva come JPEG
Nome #
Speciation and structural transformation of a VV–malate complex in the absence and in the presence of a protein: from a dinuclear species to decavanadate 306
Controlling intramolecular electronic communication through the conformation changes via stepwise oxidations in dicopper(ii) and dinickel(ii) porphyrin dimers 250
Exploiting the potential of rivastigmine-melatonin derivatives as multitarget metal-modulating drugs for neurodegenerative diseases 249
Bioinspired Oxidized Dicobalt Porphyrin Dimer-Catalyzed Cycloaddition Reactions: Cooperative Catalysis and Spectroscopic and Mechanistic Investigation 209
A Multi-Technique Investigation of the Complex Formation Equilibria between Bis-Deferiprone Derivatives and Oxidovanadium (IV) 193
Co-ordination Ability of Cu2+ ion toward the Nucleobase-Amino Acid Willardiine 191
A hexanucluear copper(II) Schiff base complex incorporating rare “bicapped cubane” core: Structural aspects, magnetic properties and EPR study 188
A 2-D coordination polymer incorporating cobalt(II), 2-sulfoterephthalate and the flexible bridging ligand 1,3-di(4-pyridyl)propane 181
5,5′-Dibenzoimidazole as building block for a new 3D Co(II) coordination polymer: A combined EPR and DFT study using UB3LYP model 179
A Ni(II) derivative incorporating tetradentate Schiff base precursor: Structure, spectral, electrochemical and DFT interpretation 172
Synthesis and characterization of vanadium(IV) complexes with cis-inositol in aqueous solution and in the solid-state 170
Vanadium(IV,V) complexes of D-saccharic and mucic acids in aqueous solution 169
A novel μ1,1-azido-, μ2-alkoxo-, and μ2-phenoxo-bridged tetranuclear copper(II) complex with a quinquedentate Schiff-base ligand: magneto-structural and DFT studies 169
A trigonal prismatic anionic iron(III) complex of a radical o-iminobenzosemiquinonate derivative: Structural and spectral analyses 168
A novel mixed valent CuII–CuI 2D framework made of a hydrazone and μ-SCN bridged metallacyclic loops cross-linked by μ3-SCN chains 166
Binding of oxovanadium(IV) to imidazole, pyrazole and thiazole ligands 166
End-to-end thiocyanato-bridged zig-zag polymers of CuII, CoII and NiII with a hydrazone ligand: EPR, magnetic susceptibility and biological study 165
A mixed valent heterometallic Cu-II/Na-I coordination polymer with sodium–phenyl bonds 162
A New CuII Coordination Polymer: Structural Elucidation, EPR and Sensing Studies for Detection of Volatile Organic Solvents 162
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 1. Coordination modes and geometry in solution and at the physiological pH 159
Temperature and solvent structure dependence of VO2+ complexes of pyridine-N-oxide derivatives and their interaction with human serum transferrin 157
Synthesis of Two New Linear Trinuclear CuII Complexes: Mechanism of Magnetic Coupling through Hybrid B3LYP Functional and CShM Studies 156
A rare cobalt(III) paramagnetic derivative incorporating 1-alkyl-2-[(o-thioalkyl)phenylazo]imidazole (SMeaaiNEt): EPR, redox and magnetic interpretation 156
A quantitative study of the biotransformation of insulin-enhancing VO(2+) compounds 153
Biorelevant reactions of the potential anti-tumor agent vanadocene dichloride 153
Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction 153
A Trimetallic Cu(II) Derivative as an Efficient and Stable Electrocatalyst for Reduction of Proton to Molecular Hydrogen 153
Binding of VIVO2+ to the Fe binding sites of human serum transferrin. A theoretical study 152
A new linear double phenoxide-bridged trinuclear Cu(II) Schiff base complex: Synthesis, crystallographic elucidation, magneto-structural 152
Covalent and non-covalent binding in vanadium–protein adducts 151
Speciation of potential anti-diabetic vanadium complexes in real serum samples 149
Electron Shuttling in High-Valent Heterobimetallic NiFe-Porphyrin Dimers: Stabilization of Ni(III) and Fe-Phenoxyl Radicals 148
Binding of Oxovanadium(IV) to Dipeptides containing Histidine and Cysteine Residues 148
A New phenoxido/trifluoroacetato bridged heterometallic Ni II2 –Cu II derivative: Structure, EPR interpretation and DFT computation 148
A Ni(II) dinuclear complex bridged by end-on azide-N and phenolate-O atoms: spectral interpretation, magnetism and biological study 148
Speciation in aqueous solution and interaction with low and high molecular mass blood bioligands of [VIVO(oda)(H2O)2], a V compound with in vitro anticancer activity 147
Chemistry of oxidomolybdenum(IV) and -(VI) complexes with ONS donor ligands: Synthesis, computational evaluation and oxo-transfer reactions 147
Elucidation of Binding Site and Chiral Specificity of Oxidovanadium Drugs with Lysozyme through Theoretical Calculations 146
Binding of potential antitumor Casiopeínas® to small proteins 145
An enolato-bridged dinuclear Cu(II) complex with a coumarin-assisted precursor: a spectral, magnetic and biological study 145
Synthesis of Nitric Oxide Donors Derived from Piloty’s Acid and Study of Their Effects on Dopamine Secretion from PC12 Cells 145
Interaction of antidiabetic vanadium compounds with hemoglobin and red blood cells and their distribution between plasma and erythrocytes 144
A new Ni(II) coordination polymer formed by bulky bis(imidazole) and 4,4′-oxybis(benzoic acid): Topological and spectral elucidation 143
Formation of Mixed‐Valence Cage‐Like Polyoxidovanadates at 37°C Upon Reaction of VIVO(acetylacetonato)2 With Lysozyme 142
Antitumoral effect of vanadium compounds in malignant melanoma cell lines 142
DFT Protocol for EPR Prediction of Paramagnetic Cu(II) Complexes and Application to Protein Binding Sites 142
Cobalt(II), manganese(IV) mononuclear and zinc(II) symmetric dinuclear complexes of an aliphatic hydrazone Schiff base ligand with diversity in coordination behaviors and supramolecular architectures: syntheses, structural elucidations, and spectroscopic characterizations 141
Nonoxido VIV complexes: Prediction of the EPR spectrum and electronic structure of simple coordination compounds and amavadin 141
Biospeciation of Potential Vanadium Drugs of Acetylacetonate in the Presence of Proteins 140
Complex formation between [(η6-p-cym)Ru(H2O)3]2+ and oligopeptides containing three histidyl moieties 139
Physicochemical, antioxidant, DNA cleaving properties and antimicrobial activity of fisetin-copper chelates 138
ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins 138
The equilibrium between the octahedral and square pyramidal form in VIVO complexes and the influence of an axial ligand on their molecular properties: a spectroscopic and DFT study 138
Integrated ESI-MS/EPR/computational characterization of the binding of metal species to proteins: vanadium drug–myoglobin application 137
Simple Coordination Geometry Descriptors Allow to Accurately Predict Metal-Binding Sites in Proteins 137
Vanadium and proteins: Uptake, transport, structure,activity and function 136
Oxovanadium(IV) binding to ligands containing donor sites of biological relevance 135
Synthesis, structure, physicochemical characterization and theoretical evaluation of non-covalent interaction energy of a polymeric copper(II)-hydrazone complex 134
Electronic structure of oxovanadium(IV) complexes of alpha-hydroxycarboxylic acids 133
Accurate prediction of vertical electronic transitions of Ni(II) coordination compounds via time dependent density functional theory 133
Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug 133
Bis- and tris(pyridyl)amine-oxidovanadium complexes: characteristics and insulin-mimetic potential 132
VIVO Complexes of Bis(imidazol-2-yl) Derivatives: a Potentiometric, Spectroscopic and DFT Study 132
Exploring polyoxidovanadate–protein interaction 131
Binding of VIV O2+ , VIV OL, VIV OL2 and VV O2 L Moieties to Proteins: X-ray/Theoretical Characterization and Biological Implications 131
The determination of the geometry of Cu(II) complexes - An EPR spectroscopy experiment 131
Antiproliferative activity of vanadium compounds: Effects on the major malignant melanoma molecular pathways 130
Solution speciation and spectral studies on oxovanadium(IV) complexes of pyridinecarboxylic acids 129
Hydrolytic and dinuclear species formed by copper(II) with di-, tri- and tetra-peptides containing proline in the second position 129
Effect of secondary interactions, steric hindrance and electric charge on the interaction of VIVO species with proteins 129
Coordination modes of hydroxamic acids in copper(II), nickel(II) and zinc(II) mixed-ligand complexes in aqueous solution 128
Synthesis, Characterisation and Insulin-Mimetic Activity of Oxovanadium(IV) Complexes with Amidrazone Derivatives 128
Rationalizing the Decavanadate(V) and Oxidovanadium(IV) Binding to G-Actin and the Competition with Decaniobate(V) and ATP 128
Synthesis, structural aspects and magnetic properties of an unusual 2D thiocyanato-bridged cobalt(II)-Schiff base network 128
A Series of Non-Oxido VIVComplexes of Dibasic ONS Donor Ligands: Solution Stability, Chemical Transformations, Protein Interactions, and Antiproliferative Activity 127
Interaction of VVO2−hydrazonates with lysozyme 127
Effect of temperature and ligand protonation on the electronic ground state in Cu(ii) polymers having unusual secondary interactions: a magnetic and catechol oxidase study 127
A rare doubly nitrato and phenoxido bridged trimetallic CuIIcomplex: EPR, antiferromagnetic coupling and theoretical rationalization 126
Structural elucidation, EPR and magnetic property of a Co(III) complex salt incorporating 4,4′-bipyridine and 5-sulfoisophthalate 126
V(IV)O complexes with bis(pyridyl) derivatives 125
Antiproliferative activity of vanadium compounds: Effects on the major malignant melanoma molecular pathways 125
Ferromagnetic exchange coupling in a new bis(l-chloro)-bridged copper(II) Schiff base complex: synthesis, structure, magnetic properties and catalytic oxidation of cycloalkanes 124
Vanadium 124
Design of nalidixic acid‑vanadium complex loaded into chitosan hybrid nanoparticles as smart strategy to inhibit bacterial growth and quorum sensing 124
Ternary complex formation between VO(IV)-picolinic acid or VO(IV)-6-methylpicolinic acid and small blood serum bioligands 124
Interaction between the low molecular mass components of blood serum and the VO(IV)-DHP system (DHP=1,2-dimethyl-3-hydroxy-4(1H)-pyridinone) 124
Determination of the hyperfine coupling constant and zero-field splitting in the ESR spectrum of Mn2+ in calcite 123
New developments in the comprehension of the biotransformation and transport of insulin-enhancing vanadium compounds in the blood serum 123
Chelating properties of EDTA-type ligands containing six-membered backbone ring toward copper ion: Structure, EPR and TD-DFT evaluation 123
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies 123
Interaction of VO2+ ion with human serum transferrin and albumin 123
Oxovanadium(IV) complexes with pyrazinecarboxylic acids: The coordinating properties of ligands with the (N-aromatic, COO-) donor set 122
Coordination ability and biological activity of a naringenin thiosemicarbazone 122
Role of Ligands in the Uptake and Reduction of V(V) Complexes in Red Blood Cells 122
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1 H )-one, with Al(III), Cu(II) and Zn(II) ions 122
Synthesis and characterization of the chemical properties of new classes of NO donors as potential dopamine releasers in the treatment of Parkinson’s disease 122
Copper(II) complexes of imidazolinone herbicides 121
Bulky bis(imidazole) and 2-sulfoterephthalate Assisted 3-D Cu(II) and 2-D Mn(II) Coordination Polymers: Topology, Diversity in Metal Containing Nodes and Spectral Elucidation 121
Unveiling VIVO2+ Binding Modes to Human Serum Albumins by an Integrated Spectroscopic–Computational Approach 120
Ternary interaction between copper(II), imidazolinone herbicides and glycylglycine 119
Totale 14.587
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.218
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.218
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022855 0 0 0 13 41 26 47 83 103 54 95 393
2022/20232.201 231 140 45 392 214 388 2 268 380 18 72 51
2023/2024538 122 74 16 37 87 25 8 17 8 5 52 87
2024/20256.599 47 73 374 113 225 244 525 1.312 2.340 866 274 206
2025/202610.494 313 2.232 2.412 1.252 801 588 1.376 300 390 494 262 74
2026/20273.529 278 790 1.079 1.382 0 0 0 0 0 0 0 0
Totale 28.628